INCR intercure.co Quarterly EPS earnings growth

Public company logo of InterCure Ltd (INCR)

Low scalability at InterCure Ltd. (INCR) due to resource dependency limits expansion, as confirmed by the percentage change in quarterly EPS. The value -71.30 indicates the current level of the metric. Growth is supported by automated irrigation systems and AI climate control, while the stability of financial results is ensured by inelastic demand for prescription products regardless of market cycles.

InterCure Ltd (INCR) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 11/15/2026

Analytical breakdowns for InterCure Ltd.

- market value and analyst target forecast:
Price Chart Canndoc|INCR - Consensus Target
- market capitalization data:
Market Capitalization InterCure Ltd|INCR - Company Buyout Price
- balance sheet net asset value indicators:
Net Assets per Single Share InterCure|INCR - Accounting Capitalization|Market Cap to Net Assets Ratio intercure.co|INCR - Aggregate Business Assets
- debt level and financial liquidity data:
Total Debt to Capital InterCure Ltd.|INCR - Long-Term Liabilities to Capital|Short-Term Debt to Equity Canndoc|INCR - Aggregate Debt Obligations|Debts to Book Capitalization InterCure Ltd.|INCR - Company Long-Term Liabilities|Company Current Liabilities InterCure|Quick Liquidity intercure.co
- earnings and market multiples details:
INCR - Final Profit|Projected Future Earnings InterCure Ltd.|INCR - Market Cap to Earnings|Projected Price to Earnings Canndoc|INCR - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization InterCure|INCR - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months InterCure|INCR - Earnings per share for the last four quarters|Quarterly EPS earnings growth intercure.co|INCR - Earnings per share growth this year|Expected earnings per share growth for next year InterCure Ltd.
- company sales and revenue statistics:
INCR - Company Gross Revenue|Projected Sales Volume InterCure Ltd.|INCR - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio InterCure Ltd
Summary company analytics:intercure.co - INCR
Flagship merchandise of intercure.co

When screening assets, an investor assesses business resilience through net profit per share dynamics, measuring the percentage change in EPS between quarters to determine capitalization rates. In GURU.Markets, the quarterly EPS evolution metric reflects the cost efficiency of InterCure Ltd. (INCR) in implementing green technologies and renewable energy, allowing for the timely identification of capital freeze risks during yield overheating.

Main competitors

Indivior Corp (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharmaceutical Inc|CRON (thecronosgroup.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth canopygrowth.com|Quarterly EPS earnings growth HITI|ACB (Aurora Cannabis, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACHV (Achieve Life Sciences, Inc)|Skye Bioscience (SKYE) - Earnings per share growth in annualized terms for the last twelve months|Anebulo Pharmaceuticals - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NTRB (nutriband.com)|Nasus Pharma Ltd (NSRX) - Year-over-year earnings per share growth for the last twelve months|India Globalization Capital - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MIRA Pharma|FLGC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months IMC (IMCC)|ADIL: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ARTL (Artelo)|Year-over-year earnings per one share growth for the last 12 months ENSC|Titan Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Greenlane Holdings|inmedpharma.com (INM) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AKAN|Year-over-year earnings per share growth for the last twelve months Enveric Corp|Earnings per share growth in annualized terms for the last twelve months brightgreen.us BGXX|Year-over-year net earnings per share growth for the last 12 months HPCO (Hempacco Co Inc.)